Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Puig

Showing results (11-20 of 423) with videos related to

Pageof 43
Sort By:
Actas Dermo-Sifiliograficas|November 8, 2015
Cytokine Pathways and the Role of Dysbiosis in Psoriasis, Psoriatic Arthritis, and Crohn DiseaseL Puig
The British Journal of Dermatology|June 1, 1997
Pharmacodynamic interaction with phototoxic plants during PUVA therapyL Puig
Journal of the European Academy of Dermatology and Venereology : JEADV|November 6, 2014
PASI90 response: the new standard in therapeutic efficacy for psoriasisL Puig
The British Journal of Dermatology|February 5, 2019
British Association of Dermatologists Biologic Interventions Register delivers: infliximab increases risk of serious infectionsL Puig
Journal of the European Academy of Dermatology and Venereology : JEADV|September 12, 2014
Defining effective approaches to the reduction or elimination of biologic therapy immunogenicity and loss of responseL Puig
Actas Dermo-Sifiliograficas|October 8, 2013
Biologic therapies for moderate to severe psoriasis are not interchangeableL Puig
The British Journal of Dermatology|December 21, 2020
Head-to-head comparison of biologics in psoriasis: better acceleration does not necessarily win all racesL Puig
Actas Dermo-Sifiliograficas|July 23, 2023
Race, Ethnicity, and Ancestry: A Short Review and Proposal for Consistent Classifications in DermatologyL Puig
The British Journal of Dermatology|March 17, 2017
Registries and biologics: disease populations matterL Puig
Journal of Clinical Pharmacy and Therapeutics|January 29, 2015
On clinical thresholds, clinical equivalents and indirect comparisons of biological treatments for moderate-to-severe psoriasisL Puig
Pageof 43

Showing results (11-20 of 423) with videos related to

Sort By:
Pageof 43
Actas Dermo-Sifiliograficas|November 8, 2015
Cytokine Pathways and the Role of Dysbiosis in Psoriasis, Psoriatic Arthritis, and Crohn DiseaseL Puig
The British Journal of Dermatology|June 1, 1997
Pharmacodynamic interaction with phototoxic plants during PUVA therapyL Puig
Journal of the European Academy of Dermatology and Venereology : JEADV|November 6, 2014
PASI90 response: the new standard in therapeutic efficacy for psoriasisL Puig
The British Journal of Dermatology|February 5, 2019
British Association of Dermatologists Biologic Interventions Register delivers: infliximab increases risk of serious infectionsL Puig
Journal of the European Academy of Dermatology and Venereology : JEADV|September 12, 2014
Defining effective approaches to the reduction or elimination of biologic therapy immunogenicity and loss of responseL Puig
Actas Dermo-Sifiliograficas|October 8, 2013
Biologic therapies for moderate to severe psoriasis are not interchangeableL Puig
The British Journal of Dermatology|December 21, 2020
Head-to-head comparison of biologics in psoriasis: better acceleration does not necessarily win all racesL Puig
Actas Dermo-Sifiliograficas|July 23, 2023
Race, Ethnicity, and Ancestry: A Short Review and Proposal for Consistent Classifications in DermatologyL Puig
The British Journal of Dermatology|March 17, 2017
Registries and biologics: disease populations matterL Puig
Journal of Clinical Pharmacy and Therapeutics|January 29, 2015
On clinical thresholds, clinical equivalents and indirect comparisons of biological treatments for moderate-to-severe psoriasisL Puig
Pageof 43